Co-Authors
This is a "connection" page, showing publications co-authored by Stephen Duncan and James Corbett.
Connection Strength
1.046
-
iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery. Front Med (Lausanne). 2019; 6:265.
Score: 0.702
-
Enhanced genome editing in human iPSCs with CRISPR-CAS9 by co-targeting ATP1a1. PeerJ. 2020; 8:e9060.
Score: 0.181
-
A Screen Using iPSC-Derived Hepatocytes Reveals NAD+ as a Potential Treatment for mtDNA Depletion Syndrome. Cell Rep. 2018 11 06; 25(6):1469-1484.e5.
Score: 0.163